Eisai Enters Into Agreement With National Cancer Center to Collaborate on Investigator-Initiated Clinical Research for Anticancer Agent Tazemetostat Based on “Patient-Proposed Healthcare Services” System
TOKYO, Apr 3, 2023 – (JCN Newswire) – Eisai Co., Ltd. announced today that it…